Details

Autor(en) / Beteiligte

• Le, Thieu Van
• Vu, Thuc Thi Minh
• Mai, Hue Thi
• Nguyen, Long Hoang
• Truong, Nu Thi
• Hoang, Chi Linh
• Nguyen, Son Hoang
• Nguyen, Cuong Tat
• Nguyen, Binh Cong
• Tran, Tung Hoang
• Tran, Bach Xuan
• Latkin, Carl A
• Ho, Cyrus S H
• Ho, Roger C M

Titel

Social Determinants of Stigma and Discrimination in Vietnamese Patients with Chronic Hepatitis B

Ist Teil von

• International journal of environmental research and public health, 2019-01, Vol.16 (3), p.398

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2019

Quelle

MEDLINE

Beschreibungen/Notizen

• Vietnam is among the countries with the highest prevalence of chronic hepatitis B (CHB) and individuals who suffer from CHB oftentimes perceive high levels of stigma and discrimination. Our study aimed to provide evidence on the prevalence of stigma against hepatitis B virus (HBV), HBV infection, and social determinants of stigma and discrimination in patients. A cross-sectional study was conducted at Viet-Tiep Hospital, Hai Phong, Vietnam. Stigma and discrimination against CHB in the last month were measured via four dimensions: (1) Blame/Judgment; (2) Shame; (3) Discrimination in different settings; (4) Disclosure of CHB status. Multivariate Logistic and Tobit regressions were used to identify factors associated with CHB-related stigma and discrimination. Among 298 enrolled patients, 4.8% experienced blame/judgement, 10.2% perceived shame, 48.5% felt discriminated in healthcare facilities, and 90.6% disclosed their health status with spouses/partners. Factors associated with lower odds of CHB-related stigma/discrimination included living with spouses/partners, old age, being employed, and the existence of comorbidities was linked with higher odds of stigma. Anti-stigma programs should target those who are younger and have comorbidities. This could be done by community-based interventions which focus on inaccurate beliefs about viral hepatitis. Furthermore, families, healthcare providers, and society should play a crucial role in supporting CHB patients.